Publication | Open Access
Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG
161
Citations
34
References
2017
Year
Continuing TMZ beyond 6 cycles was not shown to increase overall survival for newly diagnosed GBM.
| Year | Citations | |
|---|---|---|
Page 1
Page 1